Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > The Thrill is Gone...
View:
Post by gojotv! on Feb 18, 2021 12:48pm

The Thrill is Gone...

The last time TLT stock was in a doldrums like this, I bought a whole bunch at $0.13!
Thrilled with the result.
We're in a doldrums now, and the price, IMHO, should be closer to the mid-dollar mark, but...
Between news releases is the time to buy, because the next news will be spectacular!
And the only reason we want a higher % of CR is to achieve FDA breakthrough status and get fast-tracked. This is already the dominant treatment for bladder cancer. No one else can even dream of a 50% "Complete Response" (CURE!) thqt's achieved in a couple of days, is minimally invasive, and allows for recuperation at home.
No hospital stay? Are you kidding me?
Although our success rate can only increase, we're taking over this market in two years FOR SURE!
Those who don't understand Science are doomed to buy mining stock, lol!

Have a great week!
Comment by tamarindo1 on Feb 18, 2021 1:23pm
I would never classify gojo or kentuky as pumpers, instead I look on them as perennial optomists., they keep others spirits up during these boring waiting days, and that's a good thing IMO :-) 
Comment by gojotv! on Feb 18, 2021 3:07pm
You're right, tamarindo1. I'm not a pumper, because I'm not a trader. I expect the big payoffs with TLT to start in one to two years, and the GINORMOUS payoffs in five. Very much worth waiting for, IMHO, when so many day traders are tripping stop losses and undermining our faith. GLTA longs and Cancer Fighters! And may Sherri McFarland get her Nobel! Amen
Comment by GoodAtCharts on Feb 18, 2021 3:18pm
This has always been a great company but seems to always have a low price happening- great work by management IMO
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250